Nidan Laboratories and Healthcare Limited — Others, 06-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Nidan Laboratories and Healthcare Limited has confirmed that Corporate Governance provisions under SEBI regulations are not applicable for the quarter ended 31st December 2024 due to its listing under the SME portal of the National Stock Exchange. This exemption may simplify compliance burdens, potentially leading to an enhanced operational focus. From an investor perspective, this development might foster a neutral impact, as the regulatory exemption could allow the company to allocate resources towards growth initiatives rather than governance adherence, providing a clear path for operational agility.